COVID Origins, Ohio Train, ETFs, and Goldman (Podcast)
Bloomberg Intelligence
00:00
Does Pfizer Need to Do Several of These?
Pfizer is looking at companies because in their four queue results, they had a slide which showed $25 billion of risk-adjusted sales from deals to be done in 2020, 2030. So the point is they need to do big deals. And here, although Segan is not necessarily a big company today, they say $23 billion of sales,. expectations on consensus have it going up to about nine in 2030.
Play episode from 01:51
Transcript
